COVID-19-associated thyroid diseases: Difference between revisions

Jump to navigation Jump to search
Mitra Chitsazan (talk | contribs)
Mitra Chitsazan (talk | contribs)
Line 36: Line 36:


===Laboratory Findings===
===Laboratory Findings===
===Electrocardiogram===


===X-ray===
===X-ray===

Revision as of 14:16, 14 July 2022

Template:COVID-19 thyroid disorders

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:

Overview

COVID-19 has been found to affect several organs and body systems, including the endocrine system, with short-term and possible long-term consequences.

Historical Perspective

Classification

There is no established system for the classification of COVID-19-associated thyroid disorders.

Pathophysiology

Causes

Differentiating ((Page name)) from other Diseases

Epidemiology and Demographics

Risk Factors

There are no established risk factors for COVID-19-associated [[[thyroid diseases]].

Screening

There is insufficient evidence to recommend routine screening for COVID-19-associated thyroid diseases.

Natural History, Complications, and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

X-ray

Echocardiography or Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

References